ACOR - Why Acorda Therapeutics Stock Is Down Nearly 90% | Benzinga
Acorda Therapeutics Inc (NASDAQ:ACOR) shares are trading lower by 75% to $3.34 during Tuesday’s session after the company provided a series of business updates, including commencing voluntary proceedings under Chapter 11 of the United States Bankruptcy Code. Acorda on Monday canceled its fourth quarter and year-end 2023 earnings conference call. However, the company still plans to file its Annual Report on Form 10-K for the ...